Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2018, Article ID 2383715, 11 pages
https://doi.org/10.1155/2018/2383715
Research Article

Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC

1Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
2Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
3Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

Correspondence should be addressed to Yulong Wang; moc.621@kcendaeh, Yu Wang; moc.anis@031kcen, and Qinghai Ji; nc.gro.achs@iahgniqij

Received 18 December 2017; Revised 26 February 2018; Accepted 1 March 2018; Published 21 May 2018

Academic Editor: Diego Russo

Copyright © 2018 Ben Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2017,” CA: A Cancer Journal for Clinicians, vol. 67, no. 1, pp. 7–30, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA: A Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. B. R. Haugen, E. K. Alexander, K. C. Bible et al., “2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 26, no. 1, pp. 1–133, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. I. Sherma, “Thyroid carcinoma,” The Lancet, vol. 361, no. 9356, pp. 501–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Y. Lee, J. K. Won, S. H. Lee et al., “Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma,” Thyroid, vol. 26, no. 3, pp. 404–413, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Xu, T. Ibrahimpasic, L. Wang et al., “Clinicopathologic features of fatal non-anaplastic follicular cell–derived thyroid carcinomas,” Thyroid, vol. 26, no. 11, pp. 1588–1597, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Piana, M. Ragazzi, G. Tallini et al., “Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis,” Human Pathology, vol. 44, no. 4, pp. 556–565, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. C. Smallridge and J. A. Copland, “Anaplastic thyroid carcinoma: pathogenesis and emerging therapies,” Clinical Oncology, vol. 22, no. 6, pp. 486–497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Ibrahimpasic, R. Ghossein, D. L. Carlson et al., “Outcomes in patients with poorly differentiated thyroid carcinoma,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 4, pp. 1245–1252, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Ibrahimpasic, R. Ghossein, D. L. Carlson et al., “Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986–2009 Memorial Sloan-Kettering Cancer Center experience,” Thyroid, vol. 23, no. 8, pp. 997–1002, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. E. R. Fisher, R. Gregorio, R. Shoemaker, B. Horvat, and C. Hubay, “The derivation of so-called “giant-cell” and “spindle-cell” undifferentiated thyroidal neoplasms,” American Journal of Clinical Pathology, vol. 61, no. 5, pp. 680–689, 1974. View at Publisher · View at Google Scholar
  12. E. Kawahara, A. Ooi, Y. Oda, S. Katsuda, S. Terahata, and T. Michigishi, “Papillary carcinoma of the thyroid gland with anaplastic transformation in the metastatic foci. An immunohistochemical study,” Acta Pathologica Japonica, vol. 36, no. 6, pp. 921–927, 1986. View at Google Scholar
  13. Φ. Fluge, O. Bruland, L. A. Akslen, J. R. Lillehaug, and J. E. Varhaug, “Gene expression in poorly differentiated papillary thyroid carcinomas,” Thyroid, vol. 16, no. 2, pp. 161–175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H. M. Wang, Y. W. Huang, J. S. Huang et al., “Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma,” Annals of Surgical Oncology, vol. 14, no. 10, pp. 3011–3018, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Landa, T. Ibrahimpasic, L. Boucai et al., “Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers,” The Journal of Clinical Investigation, vol. 126, no. 3, pp. 1052–1066, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Xu and R. Ghossein, “Genomic landscape of poorly differentiated and anaplastic thyroid carcinoma,” Endocrine Pathology, vol. 27, no. 3, pp. 205–212, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Volante, P. Collini, Y. E. Nikiforov et al., “Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach,” The American Journal of Surgical Pathology, vol. 31, no. 8, pp. 1256–1264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Rios, J. M. Rodriguez, B. Ferri, E. Matinez-Barba, B. Febrero, and P. Parrilla, “Are prognostic scoring systems of value in patients with follicular thyroid carcinoma?” European Journal of Endocrinology, vol. 169, no. 6, pp. 821–827, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. R. M. Wong, C. Bresee, and G. D. Braunstein, “Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma,” Thyroid, vol. 23, no. 5, pp. 566–574, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. N. D. Perrier, J. D. Brierley, and R. M. Tuttle, “Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual,” CA: A Cancer Journal for Clinicians, vol. 68, no. 1, pp. 55–63, 2018. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Gao, B. Ma, L. Zhou et al., “The impact of presence of Hashimoto’s thyroiditis on diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy in subcentimeter thyroid nodules: a retrospective study from FUSCC,” Cancer Medicine, vol. 6, no. 5, pp. 1014–1022, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Pusztaszeri, “Papillary thyroid microcarcinoma associated with metastasis and fatal outcome: is the microcarcinoma an incidental finding?” Human Pathology, vol. 44, no. 9, p. 1961, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. D'Avanzo, P. Ituarte, P. Treseler et al., “Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome,” Thyroid, vol. 14, no. 6, pp. 453–458, 2004. View at Publisher · View at Google Scholar · View at Scopus